
HAO Valuation
Haoxi Health Technology Ltd
- Overview
- Forecast
- Valuation
- Earnings
HAO Relative Valuation
HAO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, HAO is overvalued; if below, it's undervalued.
Historical Valuation
Haoxi Health Technology Ltd (HAO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Haoxi Health Technology Ltd (HAO) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:1.29
Fair
0.00
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Haoxi Health Technology Ltd. (HAO) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
Haoxi Health Technology Ltd. (HAO) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
Haoxi Health Technology Ltd. (HAO) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
Haoxi Health Technology Ltd. (HAO) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
Haoxi Health Technology Ltd. (HAO) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Haoxi Health Technology Ltd (HAO) has a current Price-to-Book (P/B) ratio of 0.19. Compared to its 3-year average P/B ratio of 39.46 , the current P/B ratio is approximately -99.51% higher. Relative to its 5-year average P/B ratio of 39.46, the current P/B ratio is about -99.51% higher. Haoxi Health Technology Ltd (HAO) has a Forward Free Cash Flow (FCF) yield of approximately -94.76%. Compared to its 3-year average FCF yield of -28.48%, the current FCF yield is approximately 232.69% lower. Relative to its 5-year average FCF yield of -28.48% , the current FCF yield is about 232.69% lower.
0.20
P/B
Median3y
39.46
Median5y
39.46
-94.76
FCF Yield
Median3y
-28.48
Median5y
-28.48
Competitors Valuation Multiple
The average P/S ratio for HAO's competitors is 0.09, providing a benchmark for relative valuation. Haoxi Health Technology Ltd Corp (HAO) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of HAO increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of HAO in the past 1 year is driven by Unknown.
People Also Watch

EVGN
Evogene Ltd
1.223
USD
+1.49%

IDAI
T Stamp Inc
3.155
USD
+1.12%

KLTO
Klotho Neurosciences Inc
0.550
USD
-3.51%

BTBD
Bt Brands Inc
1.570
USD
-5.99%

GIPR
Generation Income Properties Inc
1.190
USD
+9.17%

CMCT
Creative Media & Community Trust Corporation
7.250
USD
-5.48%

PRPO
Precipio Inc
17.570
USD
+0.11%

MFI
mF International Limited
41.010
USD
-3.46%
FAQ

Is Haoxi Health Technology Ltd (HAO) currently overvalued or undervalued?
Haoxi Health Technology Ltd (HAO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Haoxi Health Technology Ltd (HAO) is between to according to relative valuation methord.

What is Haoxi Health Technology Ltd (HAO) fair value?

How does HAO's valuation metrics compare to the industry average?

What is the current P/B ratio for Haoxi Health Technology Ltd (HAO) as of Sep 18 2025?

What is the current FCF Yield for Haoxi Health Technology Ltd (HAO) as of Sep 18 2025?

What is the current Forward P/E ratio for Haoxi Health Technology Ltd (HAO) as of Sep 18 2025?
